← Leaderboards
Frederick Kofi Korley
University Of Michigan At Ann Arbor
$4,957,137
Attributed
$10,376,931
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,376,931 · 5
By mechanism
U01$6,725,548 · 1
R01$2,430,966 · 1
R61$751,266 · 1
R21$261,809 · 1
R38$207,342 · 1
Top collaborators
- Byron J. Gajewski5 shared
- Gaylan L Rockswold5 shared
- William G Barsan4 shared
- Cindy Hsing-Liang Hsu2 shared
- Renee Hebert Martin1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Ramon R Diaz-Arrastia$21,608,850
- William G Barsan$53,624,340
- William Joseph Meurer$20,176,311
- Vicki L Ellingrod$16,022,777
- Theodore S Lawrence$30,022,406
Others in their field
Other Emerging Leaders on “Brain Injuries”
- Sharon Dziuba Yeatts · University Of Michigan At Ann Arbor$13,327,946
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Vera Hoffman · Reveal Pharma$10,532,099
- Ganesh M Babulal · Washington University$10,332,120
- Romergryko Geocadin · University Of Michigan At Ann Arbor$9,719,654
- Kevin Navin Sheth · Brigham And Women'S Hospital$9,393,607
Research focus
Brain InjuriesMortalityTraumatic Brain InjuryClinical TrialsDoseMonitorInjuryPhase Iii TrialBloodTreatment TrialHyperbaric OxygenEnrollmentBiological MarkersResponseCause Of DeathTreatment EffectImproved OutcomeHyperbaric OxygenationNeurofilamentBrain CellNeurological OutcomeGlasgow Outcome ScaleBrainLight
Grant awards (17)
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial$1,740,714
U01 · FY2025 · NS
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$558,822
R01 · FY2025 · NS · contact PI
Michigan Emergency Medicine Physician-Scientist StARR Training Program$207,342
R38 · FY2025 · HL · contact PI
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC$626,120
U01 · FY2024 · NS
Development and Validation of a Clinically Relevant Swine Model of Neurologic Injury After Cardiac Arrest to Translate Neuroprotective Therapies$353,557
R61 · FY2023 · NS
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$32,604
R01 · FY2023 · NS · contact PI
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC$916,283
U01 · FY2022 · NS
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$554,057
R01 · FY2022 · NS · contact PI
Development and Validation of a Clinically Relevant Swine Model of Neurologic Injury After Cardiac Arrest to Translate Neuroprotective Therapies$397,709
R61 · FY2022 · NS
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$51,999
R01 · FY2022 · NS · contact PI
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC$1,381,257
U01 · FY2021 · NS
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$568,711
R01 · FY2021 · NS · contact PI
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$51,999
R01 · FY2021 · NS · contact PI
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial$612,774
R01 · FY2020 · NS · contact PI
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC$2,061,174
U01 · FY2019 · NS
Predicting Incident Stroke Using Blood Biomarkers of Brain Injury$123,835
R21 · FY2018 · HL · contact PI
Predicting Incident Stroke Using Blood Biomarkers of Brain Injury$137,974
R21 · FY2017 · HL · contact PI